A phase 2 study of vatalanib in metastatic melanoma patients. (2010)

First Author: Cook N
Attributed to:  Hub in Trials Methodology Research (MRC Biostatistics Unit, Cambridge) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2010.07.014

PubMed Identifier: 20800475

Publication URI: http://europepmc.org/abstract/MED/20800475

Type: Journal Article/Review

Volume: 46

Parent Publication: European journal of cancer (Oxford, England : 1990)

Issue: 15

ISSN: 0959-8049